14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $2.95 Wednesday, 1st May 2024 CLLS stock ended at $2.54. This is 0.94% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 2.52% from a day low at $2.54 to a day high of $2.60.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Feb 03, 2016 $20.95 $20.99 $19.83 $20.27 346 300
Feb 02, 2016 $22.35 $22.35 $20.66 $20.91 180 300
Feb 01, 2016 $22.70 $23.01 $21.52 $22.08 218 900
Jan 29, 2016 $22.12 $22.98 $21.84 $22.36 202 800
Jan 28, 2016 $23.31 $23.31 $21.50 $21.99 237 300
Jan 27, 2016 $24.35 $24.35 $22.73 $23.07 152 000
Jan 26, 2016 $24.32 $24.42 $23.80 $24.28 159 000
Jan 25, 2016 $24.49 $24.58 $23.54 $23.65 136 700
Jan 22, 2016 $24.03 $24.39 $23.51 $23.89 92 900
Jan 21, 2016 $23.35 $23.87 $22.96 $23.02 81 300
Jan 20, 2016 $21.95 $23.69 $21.42 $23.35 227 500
Jan 19, 2016 $22.06 $22.50 $21.82 $22.17 273 300
Jan 15, 2016 $22.77 $23.24 $22.14 $22.78 160 100
Jan 14, 2016 $24.48 $24.65 $22.96 $24.37 198 500
Jan 13, 2016 $25.59 $25.61 $23.75 $24.01 172 100
Jan 12, 2016 $25.74 $26.01 $24.80 $25.55 284 800
Jan 11, 2016 $26.76 $26.78 $23.25 $24.04 333 200
Jan 08, 2016 $27.03 $27.35 $26.43 $26.55 102 000
Jan 07, 2016 $27.26 $27.43 $26.62 $26.83 222 900
Jan 06, 2016 $28.58 $28.85 $27.90 $28.27 189 000
Jan 05, 2016 $29.78 $30.06 $29.02 $29.41 118 900
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT